Maintaining informed consent validity during lengthy research protocols

IRB Ethics and Human Research

Volumn 29, Issue 6, 2007, Pages 1-6

  Prentice, Kristen J ^a,b   Appelbaum, Paul S ^c   Conley, Robert R ^a   Carpenter, William T ^a,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VA Capitol Health Care Network   (United States)

^c College of Physicians and Surgeons ^*  (United States)

^d MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CLINICAL PROTOCOL; FEMALE; HUMAN; INFORMED CONSENT; MALE; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; PROFESSIONAL STANDARD; REPRODUCIBILITY; REVIEW; STANDARD; TIME; UNITED STATES;

ADULT; BIOMEDICAL RESEARCH; CLINICAL PROTOCOLS; ETHICS COMMITTEES, RESEARCH; FEMALE; HUMANS; INFORMED CONSENT; MALE; REPRODUCIBILITY OF RESULTS; TIME FACTORS; UNITED STATES;

EID: 37749016694     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Dunn LB, Candilis PJ, Roberts LW. Emerging empirical evidence on the ethics of schizophrenia research. Schizophrenia Bulletin 2006;3 2(0:47-68 (Epub October 19, 2005);
2. Moser DJ, Reese RL, Hey CT, et al. Using a brief intervention to improve decisional capacity in schizophrenia research. Schizophrenia Bulletin 2006;32(1):116-120 (Epub September 21, 2005).
3. Wendler D, Rackoff J. Consent for continuing research participation: What is it and when should it be obtained? IRB: Ethics & Human Research 2002;24(3):1-6.
4. Appelbaum PS, Roth LH, Lidz CW, et al. False hopes and best data; Consent to research and the therapeutic misconception. Hastings Center Report 1987;17(2):20-24;
5. Horng S, Grady C. Misunderstanding in clinical research: Distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism. IRB: Ethics & Human Research 2003;25(1):11-16;
6. Lidz CW, Appelbaum PS. The therapeutic misconception: Problems and solutions. Medical Care 2002;40(9 Suppl):V55-63;
7. Lidz CW, Appelbaum PS, Grisso T, et al. Therapeutic misconception and the appreciation of risks in clinical trials. Social Science & Medicine 2004;58(9):1 689-1697.
8. Department of Health and Human Services. Protection of Human Subjects. 45 CFR 46.
9. See ref. 2, Wendler and Rackoff 2002.
10. Olver IN, Buchanan L, Laidlaw C, et al. The adequacy of consent forms for informing patients entering oncological clinical trials. Annals of Oncology 1995;6(9):867-870;
11. Schaeffer MH, Krantz DS, Wichman A, et al. The impact of disease severity on the informed consent process in clinical research. American Journal of Medicine 1996;100(3):261-268.
12. See ref. 6, Schaeffer et al. 1996.
13. Bergler JH, Pennington AC, Metcalfe M, et al. Informed consent: How much does the patient understand? Clinical Pharmacology & Therapeutics 1980;27(4):435-440.
14. See ref. 3, Lidz 2004; Criscione LG, Sugarman J, Sanders L, et al. Informed consent in a clinical trial of a novel treatment for rheumatoid arthritis. Arthritis & Rheumatism 2003;49(3):361-367;
15. Estey A, Wilkin G, Dossetor J. Are research subjects able to retain the information they are given during the consent process? Health Law Review 1994;3(2):37-41;
16. Hassar M, Weintraub M. "Uninformed" consent and the wealthy volunteer: An analysis of patient volunteers in a clinical trial of a new anti-inflammatory drug. Clinical Pharmacology & Therapeutics 1976;20(4):379-386;
17. Lynoe N, Sandlund M, Dahlqvist G, et al. Informed consent: Study of quality of information given to participants in a clinical trial. BMJ 1991;303(6803):610-613;
18. Searight HR, Miller CK. Remembering and interpreting informed consent: A qualitative study of drug trial participants. Journal of the American Board of Family Practice 1996;9(1):14"22;
19. Sugarman J, Kass NE, Goodman SN, et al. What patients say about medical research. IRB: A Review of Human Subjects Research 1998;20(4):1-7.
20. Appelbaum PS, Roth LH. Competency to consent to research: A psychiatric overview. Archives of General Psychiatry 1982;39(8): 951-958;
21. Dunn LB, Nowrangi MA, Palmer BW, et al. Assessing decisional capacity for clinical research or treatment: A review of instruments. American Journal of Psychiatry 2006;163(8):1323-1334;
22. Sturman ED. The capacity to consent to treatment and research: A review of standardized assessment tools. Clinical Psychology Review 2005;25(7):954-974.
23. See ref. 2, Wendler and Rackoff 2002.
24. See ref. 3, Appelbaum 1987, Lidz 2002, Lidz 2004; Appelbaum PS, Lidz CW, Grisso T. Therapeutic misconception in clinical research: Frequency and risk factors. IRB: Ethics & Human Research 2004;26(2):1-8;
25. Fisher JA. Procedural misconceptions and informed consent: Insights from empirical research on the clinical trials industry. Kennedy Institute of Ethics Journal 2006; 16(31:251-268.